Allan D. Sniderman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Allan D. Sniderman has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Katherine Cianflone
Centre de Recherche Hôpital Laval, 2725 chemin Ste-Foy, Ste-Foy, Quebec, Canada G1V 4G5
4 shared publications- Benoît Lamarche
Centre Nutrition, santé et société (NUTRISS), Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec, Canada
2 shared publications - Dorairaj Prabhakaran
Centre for Chronic Disease Control
2 shared publications G. Walldius
King Gustaf V Research Institute and Karolinska Institute, Stockholm and Astra Zeneca, Mölndal, Sweden
2 shared publicationsJ Frohlich
2 shared publicationsJessica Smith
Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1
2 shared publications
Latest Publications
- Open Access
- 1 March 2009
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 55 (3) , 391-393
Targeting Targets for LDL-Lowering Therapy: Lessons from the Collaborative Atorvastatin Diabetes Study (CARDS)
- 1 March 2009
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 55 (3) , 391-393
Open AccessTargeting Targets for LDL-Lowering Therapy: Lessons from the Collaborative Atorvastatin Diabetes Study (CARDS)
- 1 April 2007
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 14 (2) , 116-123
Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to go
Getting low-density lipoprotein to the right level in patients with type 2 diabetes should be relatively easy, given the potent pharmacological therapy that is available and the fact that low-density lipoprotein C is typically normal in these patients. Getting it right means getting the target for therapy right, however. The article examines the criteria that should be used to make this choice. In comparing different parameters, three criteria, in particular, need to be taken into account: the on-treatment predictive value of any parameter; the value relative to the population of one parameter compared with another, namely which is more deviant from the norm; and the concurrent level of high-density lipoprotein. The evidence from the low-density lipoprotein-lowering trials indicates that low-density lipoprotein C is not nearly as good as non-high-density lipoprotein C as a guide for the adequacy of low-density lipoprotein lowering, or, better still, apoB, with the apoB/apoA-I ratio being clearly the best of all. The evidence from the major clinical trials indicates the best single index of the adequacy of low-density lipoprotein lowering is the apoB/apoA-I ratio. Clinical practice should adapt to clinical evidence and, therefore, guidelines should be based on apolipoproteins rather than the conventional cholesterol indices.
- 1 April 2007
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 14 (2) , 116-123
Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to go
Getting low-density lipoprotein to the right level in patients with type 2 diabetes should be relatively easy, given the potent pharmacological therapy that is available and the fact that low-density lipoprotein C is typically normal in these patients. Getting it right means getting the target for therapy right, however. The article examines the criteria that should be used to make this choice. In comparing different parameters, three criteria, in particular, need to be taken into account: the on-treatment predictive value of any parameter; the value relative to the population of one parameter compared with another, namely which is more deviant from the norm; and the concurrent level of high-density lipoprotein. The evidence from the low-density lipoprotein-lowering trials indicates that low-density lipoprotein C is not nearly as good as non-high-density lipoprotein C as a guide for the adequacy of low-density lipoprotein lowering, or, better still, apoB, with the apoB/apoA-I ratio being clearly the best of all. The evidence from the major clinical trials indicates the best single index of the adequacy of low-density lipoprotein lowering is the apoB/apoA-I ratio. Clinical practice should adapt to clinical evidence and, therefore, guidelines should be based on apolipoproteins rather than the conventional cholesterol indices.
- Open Access
- 1 February 2007
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 36 (1) , 220-225
Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis
The rates of coronary disease have accelerated dramatically amongst South Asians, driven to an important extent by the atherogenic dyslipidemia and type 2 diabetes that have become so common amongst them. These precursors of vascular disease appear at lower absolute amounts of adipose tissue in South Asians than in whites. In this paper, we set out a new hypothesis—the adipose tissue overflow hypothesis—to account for these findings. The adipose tissue mass within our bodies can be divided into three different compartments: superficial subcutaneous adipose tissue, deep subcutaneous adipose tissue and visceral adipose tissue. The superficial subcutaneous adipose tissue compartment is the primary compartment, is present throughout the body, and constitutes the vast majority of the adipose tissue in the lower limb. With energy excess, the secondary adipose tissue compartments—the deep subcutaneous (mainly upper body) and the visceral adipose tissue compartments—become more prominent. Superficial subcutaneous adipose tissue is relatively inert metabolically, whereas the other two compartments are characterized by higher transmembrane fatty acid flux rates and thus are more closely linked to dyslipidemia and dysglycemia. We hypothesize that the superficial subcutaneous adipose tissue compartment is larger in whites than in South Asians. If so, as obesity develops, South Asians exhaust the storage capacity of their superficial subcutaneous adipose tissue compartment before whites do and that is why they develop the metabolic complications of upper body obesity at lower absolute masses of adipose tissue than white people.
- 1 February 2007
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 36 (1) , 220-225
Open AccessWhy might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis
The rates of coronary disease have accelerated dramatically amongst South Asians, driven to an important extent by the atherogenic dyslipidemia and type 2 diabetes that have become so common amongst them. These precursors of vascular disease appear at lower absolute amounts of adipose tissue in South Asians than in whites. In this paper, we set out a new hypothesis—the adipose tissue overflow hypothesis—to account for these findings. The adipose tissue mass within our bodies can be divided into three different compartments: superficial subcutaneous adipose tissue, deep subcutaneous adipose tissue and visceral adipose tissue. The superficial subcutaneous adipose tissue compartment is the primary compartment, is present throughout the body, and constitutes the vast majority of the adipose tissue in the lower limb. With energy excess, the secondary adipose tissue compartments—the deep subcutaneous (mainly upper body) and the visceral adipose tissue compartments—become more prominent. Superficial subcutaneous adipose tissue is relatively inert metabolically, whereas the other two compartments are characterized by higher transmembrane fatty acid flux rates and thus are more closely linked to dyslipidemia and dysglycemia. We hypothesize that the superficial subcutaneous adipose tissue compartment is larger in whites than in South Asians. If so, as obesity develops, South Asians exhaust the storage capacity of their superficial subcutaneous adipose tissue compartment before whites do and that is why they develop the metabolic complications of upper body obesity at lower absolute masses of adipose tissue than white people.
- Open Access
- 1 October 2006
- Published by Portland Press Ltd. in The Biochemist
- Vol. 28 (5) , 13-16
Eating yourself to death: Liver cholesterol, plasma ApoB and death from atherosclerosis
Plasma apoB (apolipoprotein B) equals the total number of atherogenic lipoprotein particles in plasma. Since trapping of these particles within the arterial wall is fundamental to the pathogenesis of vascular disease, understanding the metabolic determinants of plasma apoB is key in determining the risks and therapy of vascular disease. This article attempts to demonstrate how plasma apoB is determined by the cholesterol content within hepatocytes. It also sets out a hypothesis as to how the need to maintain homoeostasis of an intracellular organelle sets off a chain of events, which ends with the death of the organism.
- 1 October 2006
- Published by Portland Press Ltd. in The Biochemist
- Vol. 28 (5) , 13-16
Open AccessEating yourself to death: Liver cholesterol, plasma ApoB and death from atherosclerosis
Plasma apoB (apolipoprotein B) equals the total number of atherogenic lipoprotein particles in plasma. Since trapping of these particles within the arterial wall is fundamental to the pathogenesis of vascular disease, understanding the metabolic determinants of plasma apoB is key in determining the risks and therapy of vascular disease. This article attempts to demonstrate how plasma apoB is determined by the cholesterol content within hepatocytes. It also sets out a hypothesis as to how the need to maintain homoeostasis of an intracellular organelle sets off a chain of events, which ends with the death of the organism.
- 15 August 2006
- Published by Portland Press Ltd. in Clinical Science
- Vol. 111 (3) , 201-207
Body composition and the apoB/apoA-I ratio in migrant Asian Indians and white Caucasians in Canada
Migrant and native South Asians appear to be at increased risk of Type II diabetes mellitus and coronary disease. The aim of the present study was to determine the relationship between the most accurate summary index of the lipoprotein-related risk of vascular disease, the apoB (apolipoprotein B-100)/apoA-I (apolipoprotein A-I) ratio, and body composition in established migrant South Asians and white Caucasians living in Canada. Men and women living in Montreal, Canada between the ages of 20–60 years were recruited for participation in the study. Subjects were excluded if they had a history of cardiovascular disease or were taking lipid-lowering medication. Individuals identified themselves as Asian Indian or Caucasian. Anthropometric measurements were collected, including weight, height, waist circumference, hip circumference and body fat percentage. Plasma samples were analysed for total cholesterol, HDL-C (high-density lipoprotein-cholesterol), apoA-I and apoB. Indian subjects had a substantially higher WHR (waist-to-hip ratio) than Caucasian subjects [men, 0.93±0.01 compared with 0.86±0.01 respectively (P<0.001); women, 0.88±0.01 compared with 0.77±0.01 respectively (P<0.0001)]. WHR correlated strongly with body fat percentage in Caucasians (men, r=0.63, P=0.0002; women, r=0.74, P<0.0001). By contrast, there was no correlation in Indians (men, r=0.22, P value not significant; women, r=0.23, P value not significant). In addition, Indian men and women had a higher apoB/A-I ratio than Caucasians [men, 0.85±0.04 compared with 0.66±0.04 respectively (P=0.001); women, 0.73±0.04 compared with 0.56±0.03 respectively (P=0.0003)]. Of interest, there were also significant correlations between the apoB/apoA-I ratio and WHR in all of the groups, except the Indian women, which were stronger than the correlation of the apoB/apoA-I ratio with BMI. On the other hand, there was no significant relationship between the apoB/apoA-I ratio and the body fat percentage in any of the groups. In conclusion, the present study confirms that, as body fat percentage increases, the distribution of body fat differs between migrant Indians and Caucasians living in Canada. It also relates differences in body fat distribution to differences in the apoB/apoA-I ratio, providing at least part of the answer as to why South Asians may be at increased risk of vascular disease.
- 15 August 2006
- Published by Portland Press Ltd. in Clinical Science
- Vol. 111 (3) , 201-207
Body composition and the apoB/apoA-I ratio in migrant Asian Indians and white Caucasians in Canada
Migrant and native South Asians appear to be at increased risk of Type II diabetes mellitus and coronary disease. The aim of the present study was to determine the relationship between the most accurate summary index of the lipoprotein-related risk of vascular disease, the apoB (apolipoprotein B-100)/apoA-I (apolipoprotein A-I) ratio, and body composition in established migrant South Asians and white Caucasians living in Canada. Men and women living in Montreal, Canada between the ages of 20–60 years were recruited for participation in the study. Subjects were excluded if they had a history of cardiovascular disease or were taking lipid-lowering medication. Individuals identified themselves as Asian Indian or Caucasian. Anthropometric measurements were collected, including weight, height, waist circumference, hip circumference and body fat percentage. Plasma samples were analysed for total cholesterol, HDL-C (high-density lipoprotein-cholesterol), apoA-I and apoB. Indian subjects had a substantially higher WHR (waist-to-hip ratio) than Caucasian subjects [men, 0.93±0.01 compared with 0.86±0.01 respectively (P<0.001); women, 0.88±0.01 compared with 0.77±0.01 respectively (P<0.0001)]. WHR correlated strongly with body fat percentage in Caucasians (men, r=0.63, P=0.0002; women, r=0.74, P<0.0001). By contrast, there was no correlation in Indians (men, r=0.22, P value not significant; women, r=0.23, P value not significant). In addition, Indian men and women had a higher apoB/A-I ratio than Caucasians [men, 0.85±0.04 compared with 0.66±0.04 respectively (P=0.001); women, 0.73±0.04 compared with 0.56±0.03 respectively (P=0.0003)]. Of interest, there were also significant correlations between the apoB/apoA-I ratio and WHR in all of the groups, except the Indian women, which were stronger than the correlation of the apoB/apoA-I ratio with BMI. On the other hand, there was no significant relationship between the apoB/apoA-I ratio and the body fat percentage in any of the groups. In conclusion, the present study confirms that, as body fat percentage increases, the distribution of body fat differs between migrant Indians and Caucasians living in Canada. It also relates differences in body fat distribution to differences in the apoB/apoA-I ratio, providing at least part of the answer as to why South Asians may be at increased risk of vascular disease.
- Open Access
- 20 April 2006
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (5) , 455-461
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA‐I ratio to identify the lipoprotein‐related risk of vascular disease
: The objective of this analysis was to demonstrate the frequency and extent of error that results from using the TC/HDL C ratio rather than the apoB/apoA‐I ratio to estimate the lipoprotein‐related risk of vascular disease within 94 667 men and 75 675 women in the Apoprotein‐related Mortality Risk (AMORIS) cohort. The odds ratio (OR) for the risk of fatal myocardial infarction was determined for 1 SD change in the apoB/apoA‐I ratio and all the conventional cholesterol ratios – TC/HDL C ratio, LDL C/HDL C ratio, non‐HDL C/HDL C ratio. In both men and women, the apoB/apoA‐I ratio was significantly greater than any of the cholesterol ratios, which, in fact, differed little. Therefore, the apoB/apoA‐I ratio was taken as the most accurate index of the lipoprotein‐related risk of vascular disease. Using Receiver Operating Characteristic analysis, it was demonstrated that the diagnostic accuracy of the apoB/apoA‐I ratio was significantly greater than any cholesterol ratio in those with an LDL cholesterol 3.6 mmol L−1. Indeed, the difference between the apoB/apoA‐I OR compared with the TC/HDL C OR progressively widened as risk increased. This suggests that the advantage of the apoB/apoA‐I ratio is greatest in the population at highest risk. The distribution of subjects by quintiles showed in both genders that whilst agreement was greatest at the extremes, even at these points there was substantial discordance between the TC/HDL C and the apoB/apoA‐I ratios. Within the middle of the distribution, less than 50% of the values were concordant. Finally, when comparing the ORs, the TC/HDL C ratio underestimated risk in 69.4% of male subjects and overestimated risk in 26.1% of male subjects, whereas in the female subjects, the TC/HDL C ratio underestimated risk in 84.9% of the subjects and overestimated risk in 12.0%. Thus, using the conventional cholesterol ratios rather than the apoB/apoA‐I ratio results in frequent and substantial error in the estimation of the lipoprotein‐related risk of vascular disease.
- 20 April 2006
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (5) , 455-461
Open AccessErrors that result from using the TC/HDL C ratio rather than the apoB/apoA‐I ratio to identify the lipoprotein‐related risk of vascular disease
: The objective of this analysis was to demonstrate the frequency and extent of error that results from using the TC/HDL C ratio rather than the apoB/apoA‐I ratio to estimate the lipoprotein‐related risk of vascular disease within 94 667 men and 75 675 women in the Apoprotein‐related Mortality Risk (AMORIS) cohort. The odds ratio (OR) for the risk of fatal myocardial infarction was determined for 1 SD change in the apoB/apoA‐I ratio and all the conventional cholesterol ratios – TC/HDL C ratio, LDL C/HDL C ratio, non‐HDL C/HDL C ratio. In both men and women, the apoB/apoA‐I ratio was significantly greater than any of the cholesterol ratios, which, in fact, differed little. Therefore, the apoB/apoA‐I ratio was taken as the most accurate index of the lipoprotein‐related risk of vascular disease. Using Receiver Operating Characteristic analysis, it was demonstrated that the diagnostic accuracy of the apoB/apoA‐I ratio was significantly greater than any cholesterol ratio in those with an LDL cholesterol 3.6 mmol L−1. Indeed, the difference between the apoB/apoA‐I OR compared with the TC/HDL C OR progressively widened as risk increased. This suggests that the advantage of the apoB/apoA‐I ratio is greatest in the population at highest risk. The distribution of subjects by quintiles showed in both genders that whilst agreement was greatest at the extremes, even at these points there was substantial discordance between the TC/HDL C and the apoB/apoA‐I ratios. Within the middle of the distribution, less than 50% of the values were concordant. Finally, when comparing the ORs, the TC/HDL C ratio underestimated risk in 69.4% of male subjects and overestimated risk in 26.1% of male subjects, whereas in the female subjects, the TC/HDL C ratio underestimated risk in 84.9% of the subjects and overestimated risk in 12.0%. Thus, using the conventional cholesterol ratios rather than the apoB/apoA‐I ratio results in frequent and substantial error in the estimation of the lipoprotein‐related risk of vascular disease.
- Open Access
- 10 April 2006
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 3 (1) , 18
Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women
Background: Asian Indian immigrants have an increased risk for developing cardiovascular disease (CVD); however, there is very little data examining how the adipokines leptin and adiponectin relate to CVD risk factors such as body fat percentage (BF%), waist to hip ratio (WHR) and the apoB/apoA1 ratio in Asian Indian men and women living in Canada. Subjects and methods: A cross-sectional study comparing leptin, adiponectin, lipoproteins and anthropometric parameters in Asian Indian men and women to Caucasian men and women (4 groups). Anthropometric data (BMI, BF%, WHR), circulating lipids (apoA1, apoB, total cholesterol, and HDL-cholesterol), leptin and adiponectin were measured. Results: Asian Indian men and women had higher leptin and lower adiponectin concentrations then Caucasian men and women, respectively. Leptin (positively) and adiponectin (negatively) correlated with anthropometric parameters and lipoproteins in all four groups. Using stepwise forward multiple regression, a model including TC/HDL-C ratio, WHR, BF%, hip circumference and waist circumference predicted 74.2% of leptin concentration in men. In women, apoB, BF%, waist circumference and age predicted 77.5% of leptin concentration. Adiponectin concentrations in men were predicted (30.2%) by HDL-C, total cholesterol, hip circumference and BF% while in women 41.2% of adiponectin concentration was predicted by the apoB/apoA1 ratio, WHR and age. Conclusion: As is evident from our data, there is a strong relationship between leptin, adiponectin, and abdominal obesity with increased CVD risk, as assessed by the apoB/apoA1 ratio. Dysregulation of these parameters may account for the increased risk of CVD in Asian Indians.
- 10 April 2006
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 3 (1) , 18
Open AccessLeptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women
Background: Asian Indian immigrants have an increased risk for developing cardiovascular disease (CVD); however, there is very little data examining how the adipokines leptin and adiponectin relate to CVD risk factors such as body fat percentage (BF%), waist to hip ratio (WHR) and the apoB/apoA1 ratio in Asian Indian men and women living in Canada. Subjects and methods: A cross-sectional study comparing leptin, adiponectin, lipoproteins and anthropometric parameters in Asian Indian men and women to Caucasian men and women (4 groups). Anthropometric data (BMI, BF%, WHR), circulating lipids (apoA1, apoB, total cholesterol, and HDL-cholesterol), leptin and adiponectin were measured. Results: Asian Indian men and women had higher leptin and lower adiponectin concentrations then Caucasian men and women, respectively. Leptin (positively) and adiponectin (negatively) correlated with anthropometric parameters and lipoproteins in all four groups. Using stepwise forward multiple regression, a model including TC/HDL-C ratio, WHR, BF%, hip circumference and waist circumference predicted 74.2% of leptin concentration in men. In women, apoB, BF%, waist circumference and age predicted 77.5% of leptin concentration. Adiponectin concentrations in men were predicted (30.2%) by HDL-C, total cholesterol, hip circumference and BF% while in women 41.2% of adiponectin concentration was predicted by the apoB/apoA1 ratio, WHR and age. Conclusion: As is evident from our data, there is a strong relationship between leptin, adiponectin, and abdominal obesity with increased CVD risk, as assessed by the apoB/apoA1 ratio. Dysregulation of these parameters may account for the increased risk of CVD in Asian Indians.
- Top Cited PapersOpen Access
- 10 February 2006
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (3) , 247-258
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
: There is abundant evidence that the risk of atherosclerotic vascular disease is directly related to plasma cholesterol levels. Accordingly, all of the national and transnational screening and therapeutic guidelines are based on total or LDL cholesterol. This presumes that cholesterol is the most important lipoprotein‐related proatherogenic risk variable. On the contrary, risk appears to be more directly related to the number of circulating atherogenic particles that contact and enter the arterial wall than to the measured concentration of cholesterol in these lipoprotein fractions. Each of the atherogenic lipoprotein particles contains a single molecule of apolipoprotein (apo) B and therefore the concentration of apo B provides a direct measure of the number of circulating atherogenic lipoproteins. Evidence from fundamental, epidemiological and clinical trial studies indicates that apo B is superior to any of the cholesterol indices to recognize those at increased risk of vascular disease and to judge the adequacy of lipid‐lowering therapy. On the basis of this evidence, we believe that apo B should be included in all guidelines as an indicator of cardiovascular risk. In addition, the present target adopted by the Canadian guideline groups of an apo B −1 in high‐risk patients should be reassessed in the light of the new clinical trial results and a new ultra‐low target of −1 be considered. The evidence also indicates that the apo B/apo A‐I ratio is superior to any of the conventional cholesterol ratios in patients without symptomatic vascular disease or diabetes to evaluate the lipoprotein‐related risk of vascular disease.
- 10 February 2006
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (3) , 247-258
Top Cited PapersOpen AccessApo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
: There is abundant evidence that the risk of atherosclerotic vascular disease is directly related to plasma cholesterol levels. Accordingly, all of the national and transnational screening and therapeutic guidelines are based on total or LDL cholesterol. This presumes that cholesterol is the most important lipoprotein‐related proatherogenic risk variable. On the contrary, risk appears to be more directly related to the number of circulating atherogenic particles that contact and enter the arterial wall than to the measured concentration of cholesterol in these lipoprotein fractions. Each of the atherogenic lipoprotein particles contains a single molecule of apolipoprotein (apo) B and therefore the concentration of apo B provides a direct measure of the number of circulating atherogenic lipoproteins. Evidence from fundamental, epidemiological and clinical trial studies indicates that apo B is superior to any of the cholesterol indices to recognize those at increased risk of vascular disease and to judge the adequacy of lipid‐lowering therapy. On the basis of this evidence, we believe that apo B should be included in all guidelines as an indicator of cardiovascular risk. In addition, the present target adopted by the Canadian guideline groups of an apo B −1 in high‐risk patients should be reassessed in the light of the new clinical trial results and a new ultra‐low target of −1 be considered. The evidence also indicates that the apo B/apo A‐I ratio is superior to any of the conventional cholesterol ratios in patients without symptomatic vascular disease or diabetes to evaluate the lipoprotein‐related risk of vascular disease.
- 12 December 2005
- Published by Portland Press Ltd. in Clinical Science
- Vol. 110 (1) , 1-9
The adipocyte life cycle hypothesis
The adipocyte life cycle hypothesis states that the metabolic properties of an adipocyte vary predictably during its life cycle: that as an adipocyte matures, it accumulates triacylglycerol (triglyceride) and becomes larger; that the rates of triacylglycerol synthesis and lipolysis are matched within adipocytes and that larger adipocytes, in general, have greater rates of triacylglycerol synthesis and, concurrently, greater rates of lipolysis and, therefore, larger adipocytes have greater rates of transmembrane fatty acid flux; and that the secretion of cytokines can also be related to adipocyte size with larger adipocytes having a more unfavourable profile of cytokine secretion than smaller adipocytes. Adipocyte location is an important modifier of this relationship and the favoured sites of adipocyte proliferation are a function of gender and the position within the life cycle of the organism at which proliferation occurs. The adipocyte life cycle hypothesis posits that the metabolic consequences of obesity depend on whether expansion of adipose tissue is achieved primarily by an increase in adipocyte number or adipocyte size. This hypothesis may explain a variety of previously unanswered clinical puzzles such as the vulnerability of many peoples from South East Asia to the adverse metabolic consequences of obesity.
- 12 December 2005
- Published by Portland Press Ltd. in Clinical Science
- Vol. 110 (1) , 1-9
The adipocyte life cycle hypothesis
The adipocyte life cycle hypothesis states that the metabolic properties of an adipocyte vary predictably during its life cycle: that as an adipocyte matures, it accumulates triacylglycerol (triglyceride) and becomes larger; that the rates of triacylglycerol synthesis and lipolysis are matched within adipocytes and that larger adipocytes, in general, have greater rates of triacylglycerol synthesis and, concurrently, greater rates of lipolysis and, therefore, larger adipocytes have greater rates of transmembrane fatty acid flux; and that the secretion of cytokines can also be related to adipocyte size with larger adipocytes having a more unfavourable profile of cytokine secretion than smaller adipocytes. Adipocyte location is an important modifier of this relationship and the favoured sites of adipocyte proliferation are a function of gender and the position within the life cycle of the organism at which proliferation occurs. The adipocyte life cycle hypothesis posits that the metabolic consequences of obesity depend on whether expansion of adipose tissue is achieved primarily by an increase in adipocyte number or adipocyte size. This hypothesis may explain a variety of previously unanswered clinical puzzles such as the vulnerability of many peoples from South East Asia to the adverse metabolic consequences of obesity.
- 1 June 2005
- Vol. 63 (6) , 232-5
If apoB is so good, why isn't everybody measuring it? One reason why we need The Netherlands Journal of Medicine!
- 1 June 2005
- Vol. 63 (6) , 232-5
If apoB is so good, why isn't everybody measuring it? One reason why we need The Netherlands Journal of Medicine!